CN1505551A - 防集聚纳米银的制备方法和用该方法制备的含防集聚纳米银的微粉及其用途 - Google Patents
防集聚纳米银的制备方法和用该方法制备的含防集聚纳米银的微粉及其用途 Download PDFInfo
- Publication number
- CN1505551A CN1505551A CNA018231578A CN01823157A CN1505551A CN 1505551 A CN1505551 A CN 1505551A CN A018231578 A CNA018231578 A CN A018231578A CN 01823157 A CN01823157 A CN 01823157A CN 1505551 A CN1505551 A CN 1505551A
- Authority
- CN
- China
- Prior art keywords
- micro mist
- nano silver
- containing anti
- silver
- coagulation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000004332 silver Substances 0.000 title claims abstract description 58
- 229910052709 silver Inorganic materials 0.000 title claims abstract description 57
- 239000000843 powder Substances 0.000 title abstract description 14
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 claims abstract description 167
- 238000000034 method Methods 0.000 claims abstract description 71
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 47
- 239000002270 dispersing agent Substances 0.000 claims abstract description 14
- 238000010438 heat treatment Methods 0.000 claims abstract description 10
- 206010061218 Inflammation Diseases 0.000 claims abstract description 8
- 239000000443 aerosol Substances 0.000 claims abstract description 5
- 235000013305 food Nutrition 0.000 claims abstract description 5
- 229940034610 toothpaste Drugs 0.000 claims abstract description 4
- 239000000606 toothpaste Substances 0.000 claims abstract description 4
- 239000000654 additive Substances 0.000 claims abstract description 3
- 239000003595 mist Substances 0.000 claims description 105
- 230000010100 anticoagulation Effects 0.000 claims description 80
- 239000002245 particle Substances 0.000 claims description 46
- 239000000835 fiber Substances 0.000 claims description 40
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 32
- 230000000844 anti-bacterial effect Effects 0.000 claims description 31
- 239000002657 fibrous material Substances 0.000 claims description 31
- 239000000243 solution Substances 0.000 claims description 30
- 239000003814 drug Substances 0.000 claims description 27
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical group [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 24
- 241000894006 Bacteria Species 0.000 claims description 21
- 239000004744 fabric Substances 0.000 claims description 17
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 claims description 17
- NDVLTYZPCACLMA-UHFFFAOYSA-N silver oxide Chemical compound [O-2].[Ag+].[Ag+] NDVLTYZPCACLMA-UHFFFAOYSA-N 0.000 claims description 16
- 206010052428 Wound Diseases 0.000 claims description 14
- 208000027418 Wounds and injury Diseases 0.000 claims description 14
- 239000007864 aqueous solution Substances 0.000 claims description 13
- -1 neopelex Chemical compound 0.000 claims description 13
- 229920000742 Cotton Polymers 0.000 claims description 12
- 230000000845 anti-microbial effect Effects 0.000 claims description 12
- 238000003756 stirring Methods 0.000 claims description 12
- 239000000126 substance Substances 0.000 claims description 12
- 239000002260 anti-inflammatory agent Substances 0.000 claims description 11
- 239000007787 solid Substances 0.000 claims description 11
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 10
- 241000233866 Fungi Species 0.000 claims description 10
- 239000000853 adhesive Substances 0.000 claims description 10
- 230000001070 adhesive effect Effects 0.000 claims description 10
- 239000010408 film Substances 0.000 claims description 10
- 241000606161 Chlamydia Species 0.000 claims description 9
- 241000204031 Mycoplasma Species 0.000 claims description 9
- 239000000839 emulsion Substances 0.000 claims description 9
- 208000015181 infectious disease Diseases 0.000 claims description 9
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 8
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 8
- 239000003638 chemical reducing agent Substances 0.000 claims description 8
- 239000008103 glucose Substances 0.000 claims description 8
- 239000000203 mixture Substances 0.000 claims description 8
- 201000007094 prostatitis Diseases 0.000 claims description 8
- 229910001923 silver oxide Inorganic materials 0.000 claims description 8
- 239000000829 suppository Substances 0.000 claims description 8
- FOIXSVOLVBLSDH-UHFFFAOYSA-N Silver ion Chemical compound [Ag+] FOIXSVOLVBLSDH-UHFFFAOYSA-N 0.000 claims description 7
- 238000000605 extraction Methods 0.000 claims description 7
- 239000011505 plaster Substances 0.000 claims description 7
- 239000007921 spray Substances 0.000 claims description 7
- 229940124599 anti-inflammatory drug Drugs 0.000 claims description 6
- 239000007924 injection Substances 0.000 claims description 6
- 238000002347 injection Methods 0.000 claims description 6
- 239000006072 paste Substances 0.000 claims description 6
- 229910001961 silver nitrate Inorganic materials 0.000 claims description 6
- 239000003826 tablet Substances 0.000 claims description 6
- 235000017166 Bambusa arundinacea Nutrition 0.000 claims description 5
- 235000017491 Bambusa tulda Nutrition 0.000 claims description 5
- 235000015334 Phyllostachys viridis Nutrition 0.000 claims description 5
- 150000008044 alkali metal hydroxides Chemical class 0.000 claims description 5
- 230000001741 anti-phlogistic effect Effects 0.000 claims description 5
- 239000011668 ascorbic acid Substances 0.000 claims description 5
- 229960005070 ascorbic acid Drugs 0.000 claims description 5
- 235000010323 ascorbic acid Nutrition 0.000 claims description 5
- 239000011425 bamboo Substances 0.000 claims description 5
- 239000007938 effervescent tablet Substances 0.000 claims description 5
- 230000001815 facial effect Effects 0.000 claims description 5
- 208000014674 injury Diseases 0.000 claims description 5
- 235000013336 milk Nutrition 0.000 claims description 5
- 239000008267 milk Substances 0.000 claims description 5
- 210000004080 milk Anatomy 0.000 claims description 5
- 229910017604 nitric acid Inorganic materials 0.000 claims description 5
- 239000000725 suspension Substances 0.000 claims description 5
- 239000006188 syrup Substances 0.000 claims description 5
- 235000020357 syrup Nutrition 0.000 claims description 5
- 230000008733 trauma Effects 0.000 claims description 5
- 239000002023 wood Substances 0.000 claims description 5
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 4
- 244000050983 Luffa operculata Species 0.000 claims description 4
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 claims description 4
- 235000014676 Phragmites communis Nutrition 0.000 claims description 4
- 206010046914 Vaginal infection Diseases 0.000 claims description 4
- 201000008100 Vaginitis Diseases 0.000 claims description 4
- 235000011114 ammonium hydroxide Nutrition 0.000 claims description 4
- 208000020670 canker sore Diseases 0.000 claims description 4
- 239000002775 capsule Substances 0.000 claims description 4
- 239000012876 carrier material Substances 0.000 claims description 4
- 239000006260 foam Substances 0.000 claims description 4
- 208000027866 inflammatory disease Diseases 0.000 claims description 4
- 239000007937 lozenge Substances 0.000 claims description 4
- 230000009385 viral infection Effects 0.000 claims description 4
- YEVQZPWSVWZAOB-UHFFFAOYSA-N 2-(bromomethyl)-1-iodo-4-(trifluoromethyl)benzene Chemical compound FC(F)(F)C1=CC=C(I)C(CBr)=C1 YEVQZPWSVWZAOB-UHFFFAOYSA-N 0.000 claims description 3
- 206010011985 Decubitus ulcer Diseases 0.000 claims description 3
- 201000004624 Dermatitis Diseases 0.000 claims description 3
- 208000004210 Pressure Ulcer Diseases 0.000 claims description 3
- 241000427313 Telephium Species 0.000 claims description 3
- 208000006374 Uterine Cervicitis Diseases 0.000 claims description 3
- 206010008323 cervicitis Diseases 0.000 claims description 3
- 238000004140 cleaning Methods 0.000 claims description 3
- 239000003599 detergent Substances 0.000 claims description 3
- 206010012601 diabetes mellitus Diseases 0.000 claims description 3
- 208000014617 hemorrhoid Diseases 0.000 claims description 3
- 238000005470 impregnation Methods 0.000 claims description 3
- 239000006210 lotion Substances 0.000 claims description 3
- 239000004745 nonwoven fabric Substances 0.000 claims description 3
- 239000006187 pill Substances 0.000 claims description 3
- STCOOQWBFONSKY-UHFFFAOYSA-N tributyl phosphate Chemical compound CCCCOP(=O)(OCCCC)OCCCC STCOOQWBFONSKY-UHFFFAOYSA-N 0.000 claims description 3
- NWZSZGALRFJKBT-KNIFDHDWSA-N (2s)-2,6-diaminohexanoic acid;(2s)-2-hydroxybutanedioic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O.NCCCC[C@H](N)C(O)=O NWZSZGALRFJKBT-KNIFDHDWSA-N 0.000 claims description 2
- 208000002874 Acne Vulgaris Diseases 0.000 claims description 2
- 238000000018 DNA microarray Methods 0.000 claims description 2
- 206010012442 Dermatitis contact Diseases 0.000 claims description 2
- 241000192125 Firmicutes Species 0.000 claims description 2
- 208000031650 Surgical Wound Infection Diseases 0.000 claims description 2
- 206010000496 acne Diseases 0.000 claims description 2
- 230000000996 additive effect Effects 0.000 claims description 2
- 235000013361 beverage Nutrition 0.000 claims description 2
- 244000144987 brood Species 0.000 claims description 2
- 208000010247 contact dermatitis Diseases 0.000 claims description 2
- JMGZBMRVDHKMKB-UHFFFAOYSA-L disodium;2-sulfobutanedioate Chemical compound [Na+].[Na+].OS(=O)(=O)C(C([O-])=O)CC([O-])=O JMGZBMRVDHKMKB-UHFFFAOYSA-L 0.000 claims description 2
- 230000003628 erosive effect Effects 0.000 claims description 2
- 150000002148 esters Chemical class 0.000 claims description 2
- IKDUDTNKRLTJSI-UHFFFAOYSA-N hydrazine monohydrate Substances O.NN IKDUDTNKRLTJSI-UHFFFAOYSA-N 0.000 claims description 2
- 210000003141 lower extremity Anatomy 0.000 claims description 2
- 210000000214 mouth Anatomy 0.000 claims description 2
- 239000013612 plasmid Substances 0.000 claims description 2
- 210000002345 respiratory system Anatomy 0.000 claims description 2
- RJDVGKCBHFINOK-UHFFFAOYSA-N tris(2-methylphenoxy)-sulfanylidene-$l^{5}-phosphane Chemical compound CC1=CC=CC=C1OP(=S)(OC=1C(=CC=CC=1)C)OC1=CC=CC=C1C RJDVGKCBHFINOK-UHFFFAOYSA-N 0.000 claims description 2
- YQLIHRFKJJQBAF-UHFFFAOYSA-N tris(3-methylbutyl) phosphate Chemical compound CC(C)CCOP(=O)(OCCC(C)C)OCCC(C)C YQLIHRFKJJQBAF-UHFFFAOYSA-N 0.000 claims description 2
- 241001148471 unidentified anaerobic bacterium Species 0.000 claims description 2
- 230000003612 virological effect Effects 0.000 claims description 2
- 241000700605 Viruses Species 0.000 claims 3
- 241001330002 Bambuseae Species 0.000 claims 2
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 claims 2
- 230000015271 coagulation Effects 0.000 claims 1
- 238000005345 coagulation Methods 0.000 claims 1
- 239000003889 eye drop Substances 0.000 claims 1
- 229940012356 eye drops Drugs 0.000 claims 1
- 239000002324 mouth wash Substances 0.000 claims 1
- 229940051866 mouthwash Drugs 0.000 claims 1
- 238000001228 spectrum Methods 0.000 abstract description 13
- 230000002421 anti-septic effect Effects 0.000 abstract description 11
- 230000001954 sterilising effect Effects 0.000 abstract description 9
- 230000003115 biocidal effect Effects 0.000 abstract description 5
- 230000004054 inflammatory process Effects 0.000 abstract description 4
- 239000002537 cosmetic Substances 0.000 abstract description 2
- 239000008187 granular material Substances 0.000 abstract description 2
- 239000012567 medical material Substances 0.000 abstract description 2
- 238000005054 agglomeration Methods 0.000 abstract 1
- 230000002776 aggregation Effects 0.000 abstract 1
- 230000028327 secretion Effects 0.000 description 24
- 238000002360 preparation method Methods 0.000 description 19
- 239000000463 material Substances 0.000 description 12
- 239000000047 product Substances 0.000 description 12
- 230000000694 effects Effects 0.000 description 11
- 238000007598 dipping method Methods 0.000 description 10
- 206010059866 Drug resistance Diseases 0.000 description 9
- 239000004094 surface-active agent Substances 0.000 description 8
- 238000005406 washing Methods 0.000 description 8
- 229940088710 antibiotic agent Drugs 0.000 description 7
- 229940079593 drug Drugs 0.000 description 7
- 239000000499 gel Substances 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 238000005516 engineering process Methods 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 230000007246 mechanism Effects 0.000 description 6
- 229920001223 polyethylene glycol Polymers 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 5
- 239000002202 Polyethylene glycol Substances 0.000 description 5
- 241000191967 Staphylococcus aureus Species 0.000 description 5
- 239000002131 composite material Substances 0.000 description 5
- 239000000470 constituent Substances 0.000 description 5
- 238000001816 cooling Methods 0.000 description 5
- 239000012153 distilled water Substances 0.000 description 5
- 239000012535 impurity Substances 0.000 description 5
- 210000003491 skin Anatomy 0.000 description 5
- 238000009423 ventilation Methods 0.000 description 5
- 241000193830 Bacillus <bacterium> Species 0.000 description 4
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 4
- 206010041925 Staphylococcal infections Diseases 0.000 description 4
- 239000003242 anti bacterial agent Substances 0.000 description 4
- 244000052616 bacterial pathogen Species 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- MYSWGUAQZAJSOK-UHFFFAOYSA-N ciprofloxacin Chemical compound C12=CC(N3CCNCC3)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1CC1 MYSWGUAQZAJSOK-UHFFFAOYSA-N 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- MOTZDAYCYVMXPC-UHFFFAOYSA-N dodecyl hydrogen sulfate Chemical compound CCCCCCCCCCCCOS(O)(=O)=O MOTZDAYCYVMXPC-UHFFFAOYSA-N 0.000 description 4
- 229940043264 dodecyl sulfate Drugs 0.000 description 4
- 239000003937 drug carrier Substances 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- 239000003623 enhancer Substances 0.000 description 4
- 230000002964 excitative effect Effects 0.000 description 4
- 208000015688 methicillin-resistant staphylococcus aureus infectious disease Diseases 0.000 description 4
- 230000035945 sensitivity Effects 0.000 description 4
- 239000002002 slurry Substances 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 231100000419 toxicity Toxicity 0.000 description 4
- 230000001988 toxicity Effects 0.000 description 4
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 3
- 206010002198 Anaphylactic reaction Diseases 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 244000025254 Cannabis sativa Species 0.000 description 3
- 208000003322 Coinfection Diseases 0.000 description 3
- 229920002261 Corn starch Polymers 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 108010010803 Gelatin Proteins 0.000 description 3
- 241000731961 Juncaceae Species 0.000 description 3
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 3
- 244000082204 Phyllostachys viridis Species 0.000 description 3
- 239000004372 Polyvinyl alcohol Substances 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- 230000036783 anaphylactic response Effects 0.000 description 3
- 208000003455 anaphylaxis Diseases 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 239000004599 antimicrobial Substances 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 239000000084 colloidal system Substances 0.000 description 3
- 239000008120 corn starch Substances 0.000 description 3
- 229940099112 cornstarch Drugs 0.000 description 3
- 230000001186 cumulative effect Effects 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 239000007884 disintegrant Substances 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- 239000008273 gelatin Substances 0.000 description 3
- 229920000159 gelatin Polymers 0.000 description 3
- 235000019322 gelatine Nutrition 0.000 description 3
- 235000011852 gelatine desserts Nutrition 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 239000008101 lactose Substances 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 239000000546 pharmaceutical excipient Substances 0.000 description 3
- 239000000825 pharmaceutical preparation Substances 0.000 description 3
- 229920002451 polyvinyl alcohol Polymers 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 229940032147 starch Drugs 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 2
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 2
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 241000222122 Candida albicans Species 0.000 description 2
- 241000193468 Clostridium perfringens Species 0.000 description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 2
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N Furan Chemical compound C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 2
- 229930182566 Gentamicin Natural products 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 239000000020 Nitrocellulose Substances 0.000 description 2
- 239000005642 Oleic acid Substances 0.000 description 2
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 2
- 241000122973 Stenotrophomonas maltophilia Species 0.000 description 2
- 208000002847 Surgical Wound Diseases 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 241000607265 Vibrio vulnificus Species 0.000 description 2
- 235000010489 acacia gum Nutrition 0.000 description 2
- 239000001785 acacia senegal l. willd gum Substances 0.000 description 2
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 2
- 206010003246 arthritis Diseases 0.000 description 2
- 150000003851 azoles Chemical class 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 229940095731 candida albicans Drugs 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 229960003405 ciprofloxacin Drugs 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 229910052802 copper Inorganic materials 0.000 description 2
- 239000010949 copper Substances 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 235000003599 food sweetener Nutrition 0.000 description 2
- 230000001408 fungistatic effect Effects 0.000 description 2
- 229940014259 gelatin Drugs 0.000 description 2
- 229960002518 gentamicin Drugs 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 230000003760 hair shine Effects 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 238000007918 intramuscular administration Methods 0.000 description 2
- 238000007913 intrathecal administration Methods 0.000 description 2
- 238000001990 intravenous administration Methods 0.000 description 2
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000002086 nanomaterial Substances 0.000 description 2
- 239000002105 nanoparticle Substances 0.000 description 2
- 229920005615 natural polymer Polymers 0.000 description 2
- 229920001220 nitrocellulos Polymers 0.000 description 2
- 239000002736 nonionic surfactant Substances 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 229920001592 potato starch Polymers 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 210000000664 rectum Anatomy 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 206010040872 skin infection Diseases 0.000 description 2
- 238000007920 subcutaneous administration Methods 0.000 description 2
- 239000003765 sweetening agent Substances 0.000 description 2
- 229920002994 synthetic fiber Polymers 0.000 description 2
- 229920001059 synthetic polymer Polymers 0.000 description 2
- 230000000472 traumatic effect Effects 0.000 description 2
- 210000001215 vagina Anatomy 0.000 description 2
- 239000005418 vegetable material Substances 0.000 description 2
- 239000000080 wetting agent Substances 0.000 description 2
- FRXSZNDVFUDTIR-UHFFFAOYSA-N 6-methoxy-1,2,3,4-tetrahydroquinoline Chemical compound N1CCCC2=CC(OC)=CC=C21 FRXSZNDVFUDTIR-UHFFFAOYSA-N 0.000 description 1
- 241000589291 Acinetobacter Species 0.000 description 1
- 229920002972 Acrylic fiber Polymers 0.000 description 1
- 241000607528 Aeromonas hydrophila Species 0.000 description 1
- 241000607522 Aeromonas sobria Species 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 208000035285 Allergic Seasonal Rhinitis Diseases 0.000 description 1
- 241000156948 Aphantopus hyperantus Species 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- 208000004926 Bacterial Vaginosis Diseases 0.000 description 1
- JKLMJPQIEWXIQC-UHFFFAOYSA-L C(CCCCCCCCCCCCCCCCC)(=O)[O-].[Mg+2].C(C)N(CC)CC.C(CCCCCCCCCCCCCCCCC)(=O)[O-] Chemical compound C(CCCCCCCCCCCCCCCCC)(=O)[O-].[Mg+2].C(C)N(CC)CC.C(CCCCCCCCCCCCCCCCC)(=O)[O-] JKLMJPQIEWXIQC-UHFFFAOYSA-L 0.000 description 1
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 1
- 241000222173 Candida parapsilosis Species 0.000 description 1
- 241000222178 Candida tropicalis Species 0.000 description 1
- 201000009030 Carcinoma Diseases 0.000 description 1
- JFPVXVDWJQMJEE-QMTHXVAHSA-N Cefuroxime Chemical compound N([C@@H]1C(N2C(=C(COC(N)=O)CS[C@@H]21)C(O)=O)=O)C(=O)C(=NOC)C1=CC=CO1 JFPVXVDWJQMJEE-QMTHXVAHSA-N 0.000 description 1
- 208000010445 Chilblains Diseases 0.000 description 1
- 206010008528 Chillblains Diseases 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 241000588919 Citrobacter freundii Species 0.000 description 1
- 241001478240 Coccus Species 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- LVGKNOAMLMIIKO-UHFFFAOYSA-N Elaidinsaeure-aethylester Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC LVGKNOAMLMIIKO-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000588697 Enterobacter cloacae Species 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 208000001640 Fibromyalgia Diseases 0.000 description 1
- 240000001238 Gaultheria procumbens Species 0.000 description 1
- 235000007297 Gaultheria procumbens Nutrition 0.000 description 1
- 229920001503 Glucan Polymers 0.000 description 1
- 206010018612 Gonorrhoea Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 235000002710 Ilex cornuta Nutrition 0.000 description 1
- 241001310146 Ilex cornuta Species 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 244000003187 Juncus effusus Species 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 241000588747 Klebsiella pneumoniae Species 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 208000027530 Meniere disease Diseases 0.000 description 1
- 244000246386 Mentha pulegium Species 0.000 description 1
- 235000016257 Mentha pulegium Nutrition 0.000 description 1
- 235000004357 Mentha x piperita Nutrition 0.000 description 1
- 229920000881 Modified starch Polymers 0.000 description 1
- 241000588771 Morganella <proteobacterium> Species 0.000 description 1
- 208000031888 Mycoses Diseases 0.000 description 1
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 1
- 241000588653 Neisseria Species 0.000 description 1
- 241000588652 Neisseria gonorrhoeae Species 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 235000010326 Osmanthus heterophyllus Nutrition 0.000 description 1
- 208000005374 Poisoning Diseases 0.000 description 1
- 229920002565 Polyethylene Glycol 400 Polymers 0.000 description 1
- 208000025844 Prostatic disease Diseases 0.000 description 1
- 241000588769 Proteus <enterobacteria> Species 0.000 description 1
- 241000588770 Proteus mirabilis Species 0.000 description 1
- 241000588767 Proteus vulgaris Species 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- 241000235342 Saccharomycetes Species 0.000 description 1
- 241000607720 Serratia Species 0.000 description 1
- 241000193996 Streptococcus pyogenes Species 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 229920004933 Terylene® Polymers 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 238000004176 ammonification Methods 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000002924 anti-infective effect Effects 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- 239000007900 aqueous suspension Substances 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000003385 bacteriostatic effect Effects 0.000 description 1
- 241000933979 bacterium 14 Species 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 229940055022 candida parapsilosis Drugs 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- GPRBEKHLDVQUJE-VINNURBNSA-N cefotaxime Chemical compound N([C@@H]1C(N2C(=C(COC(C)=O)CS[C@@H]21)C(O)=O)=O)C(=O)/C(=N/OC)C1=CSC(N)=N1 GPRBEKHLDVQUJE-VINNURBNSA-N 0.000 description 1
- 229960004261 cefotaxime Drugs 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 210000004081 cilia Anatomy 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- GXGAKHNRMVGRPK-UHFFFAOYSA-N dimagnesium;dioxido-bis[[oxido(oxo)silyl]oxy]silane Chemical compound [Mg+2].[Mg+2].[O-][Si](=O)O[Si]([O-])([O-])O[Si]([O-])=O GXGAKHNRMVGRPK-UHFFFAOYSA-N 0.000 description 1
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 229940000406 drug candidate Drugs 0.000 description 1
- 238000001493 electron microscopy Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000002389 environmental scanning electron microscopy Methods 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 229960003276 erythromycin Drugs 0.000 description 1
- LVGKNOAMLMIIKO-QXMHVHEDSA-N ethyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC LVGKNOAMLMIIKO-QXMHVHEDSA-N 0.000 description 1
- 229940093471 ethyl oleate Drugs 0.000 description 1
- 239000003777 experimental drug Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 230000000855 fungicidal effect Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 239000007902 hard capsule Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- RNQBLUNNAYFBIW-NPULLEENSA-M hexadecyl(trimethyl)azanium (2S)-2-(6-methoxynaphthalen-2-yl)propanoate Chemical compound COc1ccc2cc(ccc2c1)[C@H](C)C([O-])=O.CCCCCCCCCCCCCCCC[N+](C)(C)C RNQBLUNNAYFBIW-NPULLEENSA-M 0.000 description 1
- 235000001050 hortel pimenta Nutrition 0.000 description 1
- 229960002163 hydrogen peroxide Drugs 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 208000033065 inborn errors of immunity Diseases 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 239000000391 magnesium silicate Substances 0.000 description 1
- 235000019793 magnesium trisilicate Nutrition 0.000 description 1
- 229940099273 magnesium trisilicate Drugs 0.000 description 1
- 229910000386 magnesium trisilicate Inorganic materials 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 229960001855 mannitol Drugs 0.000 description 1
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 235000019426 modified starch Nutrition 0.000 description 1
- ZDTMSMWYJXKBEB-UHFFFAOYSA-N n,n-diethylethanamine;octadecanoic acid Chemical compound CC[NH+](CC)CC.CCCCCCCCCCCCCCCCCC([O-])=O ZDTMSMWYJXKBEB-UHFFFAOYSA-N 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 210000003928 nasal cavity Anatomy 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- 210000001331 nose Anatomy 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 239000007764 o/w emulsion Substances 0.000 description 1
- 238000003305 oral gavage Methods 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 150000002895 organic esters Chemical class 0.000 description 1
- 150000002923 oximes Chemical class 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- JLFNLZLINWHATN-UHFFFAOYSA-N pentaethylene glycol Chemical compound OCCOCCOCCOCCOCCO JLFNLZLINWHATN-UHFFFAOYSA-N 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 150000003014 phosphoric acid esters Chemical class 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 239000005020 polyethylene terephthalate Substances 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 229940116317 potato starch Drugs 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 208000028529 primary immunodeficiency disease Diseases 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- ULWHHBHJGPPBCO-UHFFFAOYSA-N propane-1,1-diol Chemical class CCC(O)O ULWHHBHJGPPBCO-UHFFFAOYSA-N 0.000 description 1
- 239000003223 protective agent Substances 0.000 description 1
- 229940007042 proteus vulgaris Drugs 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 230000000452 restraining effect Effects 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 238000004626 scanning electron microscopy Methods 0.000 description 1
- 238000003902 seawater pollution Methods 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910001467 sodium calcium phosphate Inorganic materials 0.000 description 1
- 229940023144 sodium glycolate Drugs 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229940080313 sodium starch Drugs 0.000 description 1
- 239000007901 soft capsule Substances 0.000 description 1
- 238000007711 solidification Methods 0.000 description 1
- 230000008023 solidification Effects 0.000 description 1
- 238000010129 solution processing Methods 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 238000009987 spinning Methods 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 238000000967 suction filtration Methods 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 238000013268 sustained release Methods 0.000 description 1
- 239000012730 sustained-release form Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000012209 synthetic fiber Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 235000012222 talc Nutrition 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 238000011287 therapeutic dose Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 239000000196 tragacanth Substances 0.000 description 1
- 235000010487 tragacanth Nutrition 0.000 description 1
- 229940116362 tragacanth Drugs 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- JEJAMASKDTUEBZ-UHFFFAOYSA-N tris(1,1,3-tribromo-2,2-dimethylpropyl) phosphate Chemical compound BrCC(C)(C)C(Br)(Br)OP(=O)(OC(Br)(Br)C(C)(C)CBr)OC(Br)(Br)C(C)(C)CBr JEJAMASKDTUEBZ-UHFFFAOYSA-N 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 230000010148 water-pollination Effects 0.000 description 1
- 229940046284 zinacef Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/16—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
- A61L2/23—Solid substances, e.g. granules, powders, blocks, tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/16—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
- A61L2/23—Solid substances, e.g. granules, powders, blocks, tablets
- A61L2/238—Metals or alloys, e.g. oligodynamic metals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B22—CASTING; POWDER METALLURGY
- B22F—WORKING METALLIC POWDER; MANUFACTURE OF ARTICLES FROM METALLIC POWDER; MAKING METALLIC POWDER; APPARATUS OR DEVICES SPECIALLY ADAPTED FOR METALLIC POWDER
- B22F1/00—Metallic powder; Treatment of metallic powder, e.g. to facilitate working or to improve properties
- B22F1/05—Metallic powder characterised by the size or surface area of the particles
- B22F1/054—Nanosized particles
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B22—CASTING; POWDER METALLURGY
- B22F—WORKING METALLIC POWDER; MANUFACTURE OF ARTICLES FROM METALLIC POWDER; MAKING METALLIC POWDER; APPARATUS OR DEVICES SPECIALLY ADAPTED FOR METALLIC POWDER
- B22F9/00—Making metallic powder or suspensions thereof
- B22F9/16—Making metallic powder or suspensions thereof using chemical processes
- B22F9/18—Making metallic powder or suspensions thereof using chemical processes with reduction of metal compounds
- B22F9/24—Making metallic powder or suspensions thereof using chemical processes with reduction of metal compounds starting from liquid metal compounds, e.g. solutions
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y30/00—Nanotechnology for materials or surface science, e.g. nanocomposites
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nanotechnology (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Condensed Matter Physics & Semiconductors (AREA)
- Reproductive Health (AREA)
- Physics & Mathematics (AREA)
- Composite Materials (AREA)
- Vascular Medicine (AREA)
- General Physics & Mathematics (AREA)
- Materials Engineering (AREA)
- Urology & Nephrology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Crystallography & Structural Chemistry (AREA)
- Gynecology & Obstetrics (AREA)
- Endocrinology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Materials For Medical Uses (AREA)
Abstract
本发明涉及一种制备防集聚纳米银的方法，含防集聚纳米银的微粉及其用途。本发明的方法能防止活性极强的银质纳米颗粒发生集聚。其包括在反应中加入分散剂并进行热处理。用本发明方法生产含防集聚纳米银的微粉具有广谱抗菌消炎的作用可用于制药、医疗器械、医用材料、化妆品、净化水设备中的灭器件，尤其是太空器中水的灭菌、气雾剂、食品饮料的添加剂、生物芯片中的功能性部件、洗涤剂、牙膏等日用产品中。
Description
PCT国内申请，说明书已公开。
Claims (1)
- PCT国内申请，权利要求书已公开。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB018231578A CN1224479C (zh) | 2001-04-20 | 2001-11-26 | 防集聚纳米银的制备方法和用该方法制备的含防集聚纳米银的微粉 |
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN01110767.7 | 2001-04-20 | ||
| CNB011107677A CN1179646C (zh) | 2001-04-20 | 2001-04-20 | 防集聚广谱抗菌纳米银微粉及产业化制作工艺 |
| CN01223000.6 | 2001-05-08 | ||
| CN01223000U CN2479952Y (zh) | 2001-04-20 | 2001-05-08 | 纳米银创伤贴 |
| CN01129505A CN1328819A (zh) | 2001-04-20 | 2001-06-22 | 纳米银妇科病抗菌消炎膜及其工业化生产工艺 |
| CNB011295074A CN1169529C (zh) | 2001-04-20 | 2001-06-22 | 纳米银前列腺炎抗菌消炎凝胶及其工业化生产工艺 |
| CN01129505.8 | 2001-06-22 | ||
| CN01129507.4 | 2001-06-22 | ||
| CNB018231578A CN1224479C (zh) | 2001-04-20 | 2001-11-26 | 防集聚纳米银的制备方法和用该方法制备的含防集聚纳米银的微粉 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1505551A true CN1505551A (zh) | 2004-06-16 |
| CN1224479C CN1224479C (zh) | 2005-10-26 |
Family
ID=27429906
Family Applications (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB011107677A Expired - Fee Related CN1179646C (zh) | 2001-04-20 | 2001-04-20 | 防集聚广谱抗菌纳米银微粉及产业化制作工艺 |
| CN01223000U Expired - Lifetime CN2479952Y (zh) | 2001-04-20 | 2001-05-08 | 纳米银创伤贴 |
| CNB011295074A Expired - Fee Related CN1169529C (zh) | 2001-04-20 | 2001-06-22 | 纳米银前列腺炎抗菌消炎凝胶及其工业化生产工艺 |
| CN01129505A Pending CN1328819A (zh) | 2001-04-20 | 2001-06-22 | 纳米银妇科病抗菌消炎膜及其工业化生产工艺 |
| CNB018231578A Expired - Fee Related CN1224479C (zh) | 2001-04-20 | 2001-11-26 | 防集聚纳米银的制备方法和用该方法制备的含防集聚纳米银的微粉 |
Family Applications Before (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB011107677A Expired - Fee Related CN1179646C (zh) | 2001-04-20 | 2001-04-20 | 防集聚广谱抗菌纳米银微粉及产业化制作工艺 |
| CN01223000U Expired - Lifetime CN2479952Y (zh) | 2001-04-20 | 2001-05-08 | 纳米银创伤贴 |
| CNB011295074A Expired - Fee Related CN1169529C (zh) | 2001-04-20 | 2001-06-22 | 纳米银前列腺炎抗菌消炎凝胶及其工业化生产工艺 |
| CN01129505A Pending CN1328819A (zh) | 2001-04-20 | 2001-06-22 | 纳米银妇科病抗菌消炎膜及其工业化生产工艺 |
Country Status (2)
| Country | Link |
|---|---|
| CN (5) | CN1179646C (zh) |
| WO (1) | WO2002090025A1 (zh) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102430761A (zh) * | 2011-12-12 | 2012-05-02 | 池州学院 | 一种可用于灭钉螺的水溶性纳米银的制备方法 |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7137968B1 (en) | 2000-03-13 | 2006-11-21 | Nucryst Pharmaceuticals Corp. | Transcutaneous medical device dressings and method of use |
| US6719987B2 (en) | 2000-04-17 | 2004-04-13 | Nucryst Pharmaceuticals Corp. | Antimicrobial bioabsorbable materials |
| US20030185901A1 (en) | 2000-07-27 | 2003-10-02 | Burrell Robert E. | Methods of treating conditions with a metal-containing material |
| US7001617B2 (en) | 2001-04-23 | 2006-02-21 | Nueryst Pharmaceuticals Corp. | Method of induction of apoptosis and inhibition of matrix metalloproteinases using antimicrobial metals |
| AU7832201A (en) | 2000-07-27 | 2002-02-13 | Nucryst Pharm Corp | Treatment of hyperproliferative skin disorders and diseases |
| US7008647B2 (en) | 2001-04-23 | 2006-03-07 | Nucryst Pharmaceuticals Corp. | Treatment of acne |
| US7255881B2 (en) | 2000-07-27 | 2007-08-14 | Nucryst Pharmaceuticals Corp. | Metal-containing materials |
| US6989157B2 (en) | 2000-07-27 | 2006-01-24 | Nucryst Pharmaceuticals Corp. | Dry powders of metal-containing compounds |
| US7427416B2 (en) | 2000-07-27 | 2008-09-23 | Nucryst Pharmaceuticals Corp. | Methods of treating conditions using metal-containing materials |
| ES2261659T3 (es) | 2001-04-23 | 2006-11-16 | Nucryst Pharmaceuticals Corp. | Un medicamento o una preparacion que contiene un metal tal como plata, oro, platino o paladio como un agente antimicrobiano y su uso para el tratamiento de estados inflamatorios de la piel. |
| US7201925B2 (en) | 2002-04-23 | 2007-04-10 | Nueryst Pharmaceuticals Corp. | Treatment of ungual and subungual diseases |
| WO2003101200A1 (fr) * | 2002-06-03 | 2003-12-11 | Shenzhen Tsinghua Yuanxing Nano-Material Co., Ltd. | Argent nanostructure composite |
| DE10346387A1 (de) * | 2003-10-07 | 2005-06-09 | Henkel Kgaa | Antimikrobielle Ausrüstung von Bad- und WC-Artikeln |
| EP1616926A1 (en) * | 2004-07-15 | 2006-01-18 | Interuniversitair Microelektronica Centrum ( Imec) | Slurry composition and method for chemical polishing of copper integrated with tungsten based barrier metals |
| US8399027B2 (en) | 2005-04-14 | 2013-03-19 | 3M Innovative Properties Company | Silver coatings and methods of manufacture |
| CN100386369C (zh) * | 2005-06-03 | 2008-05-07 | 陈汝霖 | 新型纳米银乳胶制品及其制作方法 |
| US20100203088A1 (en) * | 2005-06-08 | 2010-08-12 | Khandelwal Sanjeev | Silver Nanoparticle Dispersion Formulation |
| US20070166399A1 (en) | 2006-01-13 | 2007-07-19 | 3M Innovative Properties Company | Silver-containing antimicrobial articles and methods of manufacture |
| JP2009539891A (ja) * | 2006-06-16 | 2009-11-19 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング | 抗菌性炭素 |
| CN100457084C (zh) * | 2006-08-04 | 2009-02-04 | 武汉正午阳光医药生物科技有限公司 | 纳米银妇女外用抗菌凝胶的制备方法 |
| CN100396290C (zh) * | 2006-11-03 | 2008-06-25 | 段炬红 | 妇科外用抗菌泡沫剂 |
| CN101049279B (zh) * | 2007-04-30 | 2010-06-23 | 东莞市拓扑光电科技有限公司 | 一种纳米银抗菌洗发露及其制备方法 |
| US8865227B2 (en) | 2007-12-20 | 2014-10-21 | Smith & Nephew (Overseas) Limited | Metal carbonate particles and methods of making thereof |
| US8815307B2 (en) * | 2008-12-31 | 2014-08-26 | Colotex Industrial Co., Ltd. | Process for producing porous polymer masterbatch and fiber thereof having anti-bacterial and odor eliminating functions |
| CN103341642B (zh) * | 2013-07-26 | 2015-12-02 | 莆田学院 | 一种纳米银粒子的纤维素绿色合成法 |
| CN103688996B (zh) * | 2013-11-28 | 2014-12-10 | 太原理工大学 | 一种用废旧棉纤维制备载银抗菌剂的方法 |
| CN105640986A (zh) * | 2014-11-28 | 2016-06-08 | 广东工业大学 | 一种可用于肺癌和前列腺癌防治的纳米银组合物 |
| CN107598186B (zh) * | 2017-08-30 | 2019-08-20 | 苏州工业园区格云环保新材料有限公司 | 一种纳米银及其熏蒸液的制备方法 |
| CN109137490A (zh) * | 2018-06-27 | 2019-01-04 | 苏州市天翱特种织绣有限公司 | 一种棉纤维的抗菌改性方法 |
| EP3920726A1 (en) * | 2019-02-05 | 2021-12-15 | Griffith Foods International Inc. | Anti-caking agent or flow agent for a seasoning, pharmaceuticals or nutraceuticals |
| CN111763365B (zh) * | 2020-07-17 | 2022-09-02 | 安信纳米生物科技（珠海）有限公司 | 一种含有纳米银的抗菌保鲜材料及其制备方法 |
| CN113664213B (zh) * | 2021-08-04 | 2023-11-21 | 湖南伟方生命科技有限公司 | 一种纳米银抗菌液的制备方法及其应用 |
| CN114028318B (zh) * | 2021-10-14 | 2023-11-21 | 湖南伟方生命科技有限公司 | 一种男性抗菌液及其制备方法和应用 |
| CN115137681A (zh) * | 2022-06-23 | 2022-10-04 | 深圳市黄田荔枝品牌发展有限公司 | 一种荔枝面膜及其制备方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH07173022A (ja) * | 1993-12-17 | 1995-07-11 | Asahi Chem Ind Co Ltd | 抗菌剤 |
| CN1058868C (zh) * | 1994-11-26 | 2000-11-29 | 广州安信生物科技发展有限公司 | 长效广谱抗菌颗粒及其制品的制作方法 |
| JP4025839B2 (ja) * | 1996-09-12 | 2007-12-26 | Ｄｏｗａエレクトロニクス株式会社 | 銀粉および銀粉の製造方法 |
| CN1161511C (zh) * | 1999-07-27 | 2004-08-11 | 蒋建华 | 纳米银长效广谱抗菌功能性织物及其制造方法 |
| CN1266761A (zh) * | 2000-03-23 | 2000-09-20 | 南京大学 | 纳米级银粉的制备方法 |
-
2001
- 2001-04-20 CN CNB011107677A patent/CN1179646C/zh not_active Expired - Fee Related
- 2001-05-08 CN CN01223000U patent/CN2479952Y/zh not_active Expired - Lifetime
- 2001-06-22 CN CNB011295074A patent/CN1169529C/zh not_active Expired - Fee Related
- 2001-06-22 CN CN01129505A patent/CN1328819A/zh active Pending
- 2001-11-26 WO PCT/CN2001/001584 patent/WO2002090025A1/zh not_active Application Discontinuation
- 2001-11-26 CN CNB018231578A patent/CN1224479C/zh not_active Expired - Fee Related
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102430761A (zh) * | 2011-12-12 | 2012-05-02 | 池州学院 | 一种可用于灭钉螺的水溶性纳米银的制备方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1169529C (zh) | 2004-10-06 |
| WO2002090025A1 (fr) | 2002-11-14 |
| CN1328827A (zh) | 2002-01-02 |
| CN1224479C (zh) | 2005-10-26 |
| CN1328819A (zh) | 2002-01-02 |
| CN1322474A (zh) | 2001-11-21 |
| CN2479952Y (zh) | 2002-03-06 |
| CN1179646C (zh) | 2004-12-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1505551A (zh) | 防集聚纳米银的制备方法和用该方法制备的含防集聚纳米银的微粉及其用途 | |
| TWI305535B (en) | Chemically modified polyaminosaccharide by a hydrocarbyl sultone compound | |
| WO2019211960A1 (ja) | 複合組成物 | |
| CN101716362B (zh) | 一种含二氧化氯的杀菌消毒材料及其应用 | |
| US10525147B2 (en) | Bionanocomposite synthesis for would healing | |
| CN103340816A (zh) | 一种专用于女性的私密护理湿巾 | |
| CN107137754A (zh) | 一种无析出抗菌卫生棉、制备方法及应用 | |
| CN104922310A (zh) | 一种抑菌功能的中药组合物及在日用品中的应用 | |
| CN106309401A (zh) | 一种用于预防和治疗皮肤疾病的沐浴泡腾片 | |
| CN108273118A (zh) | 含氧化石墨烯-铜银纳米复合物的中药抗菌卫生巾 | |
| CN105534372B (zh) | 一种具有抑菌、消毒作用的小解巾及其制备方法 | |
| CN107982277B (zh) | 一种复合抗菌气雾剂及其制备方法和应用 | |
| CN105662727A (zh) | 一种远红外线负氧离子卫生巾 | |
| CN103316262A (zh) | 一种妇科外用抗菌液及其制备方法 | |
| CN106806067A (zh) | 一种纳米抗菌型卫生棉条的制备工艺 | |
| CN106620814B (zh) | 抗菌护垫 | |
| CN105640409B (zh) | 一种具有抑菌、消毒作用的小解巾及其制备方法 | |
| CN1379146A (zh) | 复合型(Ag+Ag2O)防集聚纳米银抗菌非织造布及工业化生产工艺 | |
| CN1369206A (zh) | 钠米银消毒凝胶及其制备方法和应用 | |
| CN105560498B (zh) | 一种具有抑菌、消毒作用的药液及其应用 | |
| CN109602868A (zh) | 植物精华液及其制备方法和卫生巾应用 | |
| CN105534373B (zh) | 一种具有抑菌、消毒作用的小解巾及其制备方法 | |
| CN108434509A (zh) | 可拆卸含氧化石墨烯-铜银纳米复合物的中药抗菌纸尿裤 | |
| CN114652767A (zh) | 一种奶牛乳头药浴剂及其制备方法 | |
| CN114469530A (zh) | 纳米银抗菌卫生巾 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: SHENZHEN CITY YUANXING BIOLOGY PHARMACEUTICAL TEC Free format text: FORMER OWNER: SHENZHEN CITY YUANXING NANOMETER MATERIALS CO., LTD. Effective date: 20070831 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| C56 | Change in the name or address of the patentee |
Owner name: SHENZHEN CITY YUANXING NANOMETER MATERIALS CO., LT Free format text: FORMER NAME OR ADDRESS: SHENZHEN TSINGHUA YUANXING NAN |
|
| CP03 | Change of name, title or address |
Address after: China Shenzhen hi tech Development Zone North District Lang Road Patentee after: Shenzhen Yuanxing nano material Co.,Ltd. Address before: China Shenzhen hi tech Development Zone North District Lang Road Patentee before: Shenzhen Tsinghua Yuanxing Nano Material Co.,Ltd. |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20070831 Address after: 518057, Shenzhen hi tech Development Zone, North District, Lang Shan Road Patentee after: BIO-PHARM SCIENCE & TECHNOLOGY Co.,Ltd. Address before: China Shenzhen hi tech Development Zone North District Lang Road Patentee before: Shenzhen Yuanxing nano material Co.,Ltd. |
|
| EE01 | Entry into force of recordation of patent licensing contract |
Assignee: SHENZHEN YUANXING NANO PHARMACEUTICAL TECHNOLOGY CO.,LTD. Assignor: BIO-PHARM SCIENCE & TECHNOLOGY Co.,Ltd. Contract record no.: 2010440020104 Denomination of invention: Mathod for preparing micro powder containing anti-agglomerated nanometer silver, micro powder produced by the mathod and its application Granted publication date: 20051026 License type: Exclusive License Open date: 20040616 Record date: 20100706 |
|
| ASS | Succession or assignment of patent right |
Owner name: SHENZHEN YUANXING NANO-PHARMA CO.,LTD. Free format text: FORMER OWNER: SHENZHEN YUANXING BIO-PHARM CO., LTD. Effective date: 20150909 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20150909 Address after: 518000 Guangdong city of Shenzhen province Nanshan District high tech Industrial Park, North Central Avenue, North Song Ping Road No. 1 Lite technology building south 10 layer 1001 Patentee after: SHENZHEN YUANXING NANO PHARMACEUTICAL TECHNOLOGY CO.,LTD. Address before: China Shenzhen hi tech Development Zone North District Lang Road Patentee before: BIO-PHARM SCIENCE & TECHNOLOGY Co.,Ltd. |
|
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20051026 Termination date: 20181126 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |